Home › Companies › Emergent BioSolutions Inc. › 2025-2026

Emergent BioSolutions Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Emergent BioSolutions Inc.’s Form 8-K, filed 2026-04-30 (Item 5.07 on EDGAR). Page generated 02 October 2026.

8Reported items
209Asset managers
1,541Fund votes
2026-04-29Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Emergent BioSolutions Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Emergent BioSolutions Inc.

These tallies are Emergent BioSolutions Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-04-30 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Emergent BioSolutions Inc. — official shareholder meeting results, meeting held 2026-04-29
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Sujata Dayal	29,593,251	--	--	1,466,690	9,286,731	Majority: yes
Elect Director: John Fowler, Jr.	30,647,734	--	--	412,207	9,286,731	Majority: yes
Elect Director: Zsolt Harsanyi, Ph.D.	28,672,319	--	--	2,387,622	9,286,731	Majority: yes
Elect Director: Joseph Papa	29,271,291	--	--	1,788,650	9,286,731	Majority: yes
Proposal 2: approved. The voting results were as follows:	38,947,477	1,271,938	127,257	--	--	Majority: yes
Proposal 3: approved. The voting results were as follows:	18,187,878	11,988,552	883,511	--	9,286,731	Majority: yes
Proposal 4: approved. The voting results were as follows:	16,972,952	14,023,162	63,827	--	9,286,731	Majority: yes

Source: Emergent BioSolutions Inc., Form 8-K, filed with the SEC on 2026-04-30 — read the filing on EDGAR.

How asset managers voted at the Emergent BioSolutions Inc. 2025-2026 meeting

Each item below shows how the 209 asset managers that disclosed a Emergent BioSolutions Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Emergent BioSolutions Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. TO HOLD, ON AN ADVISORY BASIS, A VOTE TO APPROVE THE 2025 COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

SECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

58% fund support · no official result

FOR 56%AGAINST 41%

The 200 asset managers below cast 58% of the shares they voted on this item FOR (15,732,457 for, 11,531,623 against).

FOR: 15,732,457 (56.1%)AGAINST: 11,531,623 (41.1%)ABSTAIN: 790,546 (2.8%)

Largest asset managers voting on “TO HOLD, ON AN ADVISORY BASIS, A VOTE TO APPROVE THE 2025 COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.” at Emergent BioSolutions Inc., 2025-2026
Asset manager	For	Against	Abstain	Vote
American Century	0	4,705,328	0	Against
Vanguard	3,648,414	10,833	3	For
Charles Schwab	3,244,387	0	0	For
BlackRock	2,896,286	11,239	0	For
Dimensional	0	1,351,909	0	Against
State Street	1,203,391	135,109	0	For
ACADIAN ASSET MANAGEMENT LLC	0	882,155	0	Against
Federated Hermes	848,205	0	0	For
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.	0	0	772,771	Abstain
NEW YORK STATE COMMON RETIREMENT FUND	0	513,904	0	Against
PALISADE CAPITAL MANAGEMENT, LP	0	475,003	0	Against
SEI	423,412	0	0	For
Northern Trust	399,281	5,580	0	For
LSV ASSET MANAGEMENT	382,400	0	0	For
PIMCO	0	332,101	0	Against
GEODE CAPITAL MANAGEMENT, LLC	328,968	0	0	For
Goldman Sachs	303,509	0	0	For
O'SHAUGHNESSY ASSET MANAGEMENT, LLC	0	274,106	0	Against
Fidelity	242,880	9,655	0	For
Connor, Clark & Lunn Investment Management Ltd.	0	246,220	0	Against
Ancora Advisors LLC	0	243,052	0	Against
DE Shaw	0	230,369	0	Against
Russell Investments	170,891	0	0	For
Prudential/PGIM	151,235	7,370	0	For
PARAMETRIC PORTFOLIO ASSOCIATES LLC	0	157,449	0	Against

Showing the 25 largest of 200 asset managers. See all 200 in the interactive database.

2. To approve an amendment to the Emergent BioSolutions Inc Amended and Restated Stock Incentive Plan to increase the number of shares of common stock for the grant of awards under the plan.

COMPENSATION

Combines 4 wordings of this item as funds reported it.

56% fund support · no official result

FOR 56%AGAINST 44%

The 63 asset managers below cast 56% of the shares they voted on this item FOR (7,272,095 for, 5,663,553 against).

FOR: 7,272,095 (56.2%)AGAINST: 5,663,553 (43.8%)ABSTAIN: 7,412 (0.1%)

Largest asset managers voting on “To approve an amendment to the Emergent BioSolutions Inc Amended and Restated Stock Incentive Plan to increase” at Emergent BioSolutions Inc., 2025-2026
Asset manager	For	Against	Vote
Vanguard	3,277,509	4,170	For
American Century	0	2,310,609	Against
Charles Schwab	1,622,170	0	For
BlackRock	1,326,492	0	For
Dimensional	0	1,082,047	Against
State Street	388,026	123,182	For
Federated Hermes	0	401,190	Against
PIMCO	0	332,101	Against
Fidelity	0	203,544	Against
SEI	184,262	0	For
Northern Trust	0	178,346	Against
Goldman Sachs	0	144,838	Against
Equitable	87,239	33,040	For
TIAA	0	100,266	Against
QUANTITATIVE MASTER SERIES LLC	85,455	0	For
Capitol Series Trust	0	81,655	Against
AMERICAN BEACON FUNDS	0	80,650	Against
WisdomTree	0	79,561	Against
Direxion Shares ETF Trust	0	67,083	Against
JAMES ADVANTAGE FUNDS	0	61,660	Against
TARGET PORTFOLIO TRUST	60,200	0	For
Pacific Life	22,398	33,456	Against
SEI Exchange Traded Funds	54,609	0	For
Jackson National	0	50,649	Against
Russell Investments	47,014	0	For

Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.

3. To elect four Class II directors to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Sujata Dayal

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%

FOR: 29,593,251WITHHELD: 1,466,690

Emergent BioSolutions Inc.’s own tally for this item (“Elect Director: Sujata Dayal”): 29,593,251 for, 1,466,690 withheld, per its Form 8-K filed 2026-04-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,800,000 outstanding shares: 57% for, 3% withheld (60% of the company cast a for/withheld vote).

The 61 asset managers below cast 100% of the shares they voted on this item FOR (12,894,807 for, 0 against).

FOR 99.6%

FOR: 12,894,807 (99.6%)ABSTAIN: 46,685 (0.4%)

Largest asset managers voting on “To elect four Class II directors to hold office for a term expiring at our 2029 Annual Meeting of Stockholders” at Emergent BioSolutions Inc., 2025-2026
Asset manager	For	Abstain	Vote
Vanguard	3,277,537	4,142	For
American Century	2,310,609	0	For
Charles Schwab	1,622,170	0	For
BlackRock	1,326,492	0	For
Dimensional	1,082,047	0	For
State Street	510,698	510	For
Federated Hermes	401,190	0	For
PIMCO	332,101	0	For
Fidelity	203,544	0	For
SEI	184,262	0	For
Northern Trust	178,346	0	For
Goldman Sachs	144,838	0	For
Equitable	87,239	33,040	For
TIAA	100,266	0	For
QUANTITATIVE MASTER SERIES LLC	85,455	0	For
Capitol Series Trust	81,655	0	For
AMERICAN BEACON FUNDS	80,650	0	For
WisdomTree	79,561	0	For
Direxion Shares ETF Trust	67,083	0	For
JAMES ADVANTAGE FUNDS	61,660	0	For
TARGET PORTFOLIO TRUST	60,200	0	For
Pacific Life	55,854	0	For
SEI Exchange Traded Funds	54,609	0	For
Jackson National	50,649	0	For
Russell Investments	47,014	0	For

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

4. To elect four Class II directors to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: John Fowler, Jr.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 30,647,734WITHHELD: 412,207

Emergent BioSolutions Inc.’s own tally for this item (“Elect Director: John Fowler, Jr.”): 30,647,734 for, 412,207 withheld, per its Form 8-K filed 2026-04-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,800,000 outstanding shares: 59% for, 0.8% withheld (60% of the company cast a for/withheld vote).

The 61 asset managers below cast 100% of the shares they voted on this item FOR (12,941,491 for, 0 against).

FOR 99.9%

FOR: 12,941,491 (100.0%)ABSTAIN: 1 (0.0%)

Largest asset managers voting on “To elect four Class II directors to hold office for a term expiring at our 2029 Annual Meeting of Stockholders” at Emergent BioSolutions Inc., 2025-2026
Asset manager	For	Abstain	Vote
Vanguard	3,281,677	1	For
American Century	2,310,609	0	For
Charles Schwab	1,622,170	0	For
BlackRock	1,326,492	0	For
Dimensional	1,082,047	0	For
State Street	511,208	0	For
Federated Hermes	401,190	0	For
PIMCO	332,101	0	For
Fidelity	203,544	0	For
SEI	184,262	0	For
Northern Trust	178,346	0	For
Goldman Sachs	144,838	0	For
Equitable	120,279	0	For
TIAA	100,266	0	For
QUANTITATIVE MASTER SERIES LLC	85,455	0	For
Capitol Series Trust	81,655	0	For
AMERICAN BEACON FUNDS	80,650	0	For
WisdomTree	79,561	0	For
Direxion Shares ETF Trust	67,083	0	For
JAMES ADVANTAGE FUNDS	61,660	0	For
TARGET PORTFOLIO TRUST	60,200	0	For
Pacific Life	55,854	0	For
SEI Exchange Traded Funds	54,609	0	For
Jackson National	50,649	0	For
Russell Investments	47,014	0	For

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

5. To elect four Class II directors to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Zsolt Harsanyi, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%8%

FOR: 28,672,319WITHHELD: 2,387,622

Emergent BioSolutions Inc.’s own tally for this item (“Elect Director: Zsolt Harsanyi, Ph.D.”): 28,672,319 for, 2,387,622 withheld, per its Form 8-K filed 2026-04-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,800,000 outstanding shares: 55% for, 5% withheld (60% of the company cast a for/withheld vote).

The 61 asset managers below cast 100% of the shares they voted on this item FOR (12,742,912 for, 0 against).

FOR 98%

FOR: 12,742,912 (98.5%)ABSTAIN: 198,580 (1.5%)

Largest asset managers voting on “To elect four Class II directors to hold office for a term expiring at our 2029 Annual Meeting of Stockholders” at Emergent BioSolutions Inc., 2025-2026
Asset manager	For	Abstain	Vote
Vanguard	3,275,605	6,074	For
American Century	2,310,609	0	For
Charles Schwab	1,622,170	0	For
BlackRock	1,326,492	0	For
Dimensional	1,082,047	0	For
State Street	510,683	525	For
Federated Hermes	401,190	0	For
PIMCO	332,101	0	For
Fidelity	203,544	0	For
SEI	184,262	0	For
Northern Trust	0	178,346	Abstain
Goldman Sachs	144,838	0	For
Equitable	120,279	0	For
TIAA	100,266	0	For
QUANTITATIVE MASTER SERIES LLC	85,455	0	For
Capitol Series Trust	81,655	0	For
AMERICAN BEACON FUNDS	80,650	0	For
WisdomTree	79,561	0	For
Direxion Shares ETF Trust	67,083	0	For
JAMES ADVANTAGE FUNDS	61,660	0	For
TARGET PORTFOLIO TRUST	60,200	0	For
Pacific Life	55,854	0	For
SEI Exchange Traded Funds	54,609	0	For
Jackson National	50,649	0	For
Russell Investments	47,014	0	For

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

6. To elect four Class II directors to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Joseph Papa

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%

FOR: 29,271,291WITHHELD: 1,788,650

Emergent BioSolutions Inc.’s own tally for this item (“Elect Director: Joseph Papa”): 29,271,291 for, 1,788,650 withheld, per its Form 8-K filed 2026-04-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,800,000 outstanding shares: 57% for, 3% withheld (60% of the company cast a for/withheld vote).

The 61 asset managers below cast 100% of the shares they voted on this item FOR (12,939,556 for, 0 against).

FOR 99.9%

FOR: 12,939,556 (100.0%)ABSTAIN: 1,936 (0.0%)

Largest asset managers voting on “To elect four Class II directors to hold office for a term expiring at our 2029 Annual Meeting of Stockholders” at Emergent BioSolutions Inc., 2025-2026
Asset manager	For	Abstain	Vote
Vanguard	3,279,742	1,936	For
American Century	2,310,609	0	For
Charles Schwab	1,622,170	0	For
BlackRock	1,326,492	0	For
Dimensional	1,082,047	0	For
State Street	511,208	0	For
Federated Hermes	401,190	0	For
PIMCO	332,101	0	For
Fidelity	203,544	0	For
SEI	184,262	0	For
Northern Trust	178,346	0	For
Goldman Sachs	144,838	0	For
Equitable	120,279	0	For
TIAA	100,266	0	For
QUANTITATIVE MASTER SERIES LLC	85,455	0	For
Capitol Series Trust	81,655	0	For
AMERICAN BEACON FUNDS	80,650	0	For
WisdomTree	79,561	0	For
Direxion Shares ETF Trust	67,083	0	For
JAMES ADVANTAGE FUNDS	61,660	0	For
TARGET PORTFOLIO TRUST	60,200	0	For
Pacific Life	55,854	0	For
SEI Exchange Traded Funds	54,609	0	For
Jackson National	50,649	0	For
Russell Investments	47,014	0	For

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

7. TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.

AUDIT-RELATED

Combines 2 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 61 asset managers below cast 99.9% of the shares they voted on this item FOR (12,939,542 for, 1,949 against).

FOR: 12,939,542 (100.0%)AGAINST: 1,949 (0.0%)

Largest asset managers voting on “TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FI” at Emergent BioSolutions Inc., 2025-2026
Asset manager	For	Against	Vote
Vanguard	3,279,743	1,934	For
American Century	2,310,609	0	For
Charles Schwab	1,622,170	0	For
BlackRock	1,326,492	0	For
Dimensional	1,082,047	0	For
State Street	511,193	15	For
Federated Hermes	401,190	0	For
PIMCO	332,101	0	For
Fidelity	203,544	0	For
SEI	184,262	0	For
Northern Trust	178,346	0	For
Goldman Sachs	144,838	0	For
Equitable	120,279	0	For
TIAA	100,266	0	For
QUANTITATIVE MASTER SERIES LLC	85,455	0	For
Capitol Series Trust	81,655	0	For
AMERICAN BEACON FUNDS	80,650	0	For
WisdomTree	79,561	0	For
Direxion Shares ETF Trust	67,083	0	For
JAMES ADVANTAGE FUNDS	61,660	0	For
TARGET PORTFOLIO TRUST	60,200	0	For
Pacific Life	55,854	0	For
SEI Exchange Traded Funds	54,609	0	For
Jackson National	50,649	0	For
Russell Investments	47,014	0	For

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

8. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

0.6% fund support · no official result

AGAINST 99.4%

The 5 asset managers below cast 0.6% of the shares they voted on this item FOR (1,230 for, 219,479 against).

FOR: 1,230 (0.6%)AGAINST: 219,479 (99.4%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at Emergent BioSolutions Inc., 2025-2026
Asset manager	For	Against	Vote
GLOBEFLEX CAPITAL L P	0	217,171	Against
Integrated Quantitative Investments LLC	0	2,308	Against
Convergence Investment Partners, LLC	1,116	0	For
Coyle Financial Counsel LLC	114	0	For
Torrey Growth & Income Advisors	0	0	--

Largest Emergent BioSolutions Inc. shareholders voting in 2025-2026

Ranked by the number of Emergent BioSolutions Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 51,800,000 shares outstanding at the time of that meeting.

Top Emergent BioSolutions Inc. shareholders by shares voted, 2025-2026
#	Asset manager	% of shares outstanding
1	American Century	9.08%
2	Vanguard	7.06%
3	Charles Schwab	6.26%
4	BlackRock	5.61%
5	Dimensional	2.61%
6	State Street	2.58%
7	ACADIAN ASSET MANAGEMENT LLC	1.70%
8	Federated Hermes	1.64%
9	PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.	1.49%
10	NEW YORK STATE COMMON RETIREMENT FUND	0.99%

Reported Emergent BioSolutions Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Emergent BioSolutions Inc. beneficial owners on record for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
BlackRock	8.38%	13F
Oak Hill Advisors, L.P.	6.98%	DEF14A
Vanguard Group	6.86%	13F
Dimensional Fund Advisors	5.32%	13F
STATE STREET CORPORATION	5.21%	13G
American Century ETF Trust	5.17%	13G
Charles Schwab	2.91%	13F
Morgan Stanley	2.23%	13F
D.E. Shaw	1.94%	13F
Goldman Sachs	1.57%	13F

Percentages above are of 51,800,000 shares outstanding, as reported by Emergent BioSolutions Inc. on its Form 10-Q dated 2026-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Emergent BioSolutions Inc.’s 10-Q dated 2026-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Emergent BioSolutions Inc.'s shareholder meeting held 2026-04-29, in the 2025-2026 proxy season, 209 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,541 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. Emergent BioSolutions Inc.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — TO HOLD, ON AN ADVISORY BASIS, A VOTE TO APPROVE THE 2025 COMPENSATION OF OUR NAMED EXECUTIVE… — the reporting funds cast 58% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

Emergent BioSolutions Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).